BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Arbutus Provides 2025 Corporate and Financial Update

  January 14, 2025

   · 

  11 min read
• Press Releases

  X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand

  January 14, 2025

   · 

  8 min read
• Press Releases

  Cytokinetics Announces 2025 Corporate Milestones and Vision 2030

  January 14, 2025

   · 

  7 min read
• Press Releases

  Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025

  January 14, 2025

   · 

  12 min read
• Press Releases

  Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases

  January 14, 2025

   · 

  10 min read
• Press Releases

  ARS Pharmaceuticals Announces Preliminary Fourth Quarter 2024 Financial Results and 2025 Objectives for neffy® (epinephrine nasal spray)

  January 14, 2025

   · 

  11 min read
• Press Releases

  Immunovant Announces $450 Million Private Placement

  January 14, 2025

   · 

  3 min read
• Press Releases

  Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors

  January 14, 2025

   · 

  4 min read
• Press Releases

  Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance

  January 14, 2025

   · 

  8 min read
• Press Releases

  Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

  January 14, 2025

   · 

  10 min read